GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. Revenue 2010–2020
GT Biopharma, Inc. annual/quarterly revenue history and growth rate from 2010 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- GT Biopharma, Inc. revenue for the quarter ending September 30, 2021 was 0.
- GT Biopharma, Inc. revenue for the twelve months ending September 30, 2021 was 0.
- GT Biopharma, Inc. annual revenue for 2020 was 0.
- GT Biopharma, Inc. annual revenue for 2019 was 0.
- GT Biopharma, Inc. annual revenue for 2017 was 0.
- GT Biopharma, Inc. annual revenue for 2016 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GT Biopharma, Inc. (GTBP) — Frequently Asked Questions
GT Biopharma, Inc. (GTBP) is a publicly traded US company. It has a market capitalization of $2M. Explore GTBP's stock price, financial statements, earnings history, margins and key ratios below.
What is GT Biopharma, Inc.'s market cap?
GT Biopharma, Inc. (GTBP) has a market capitalization of $2M.
What is the GTBP stock price?
GTBP trades at $0.41 (-1.08% on the day).
Is GTBP profitable?
In fiscal 2020, GT Biopharma, Inc. reported net income of -$28M.